Get started
Author

Özlem Kutlu

Observed names: O. Kutlu, Ozlem Kutlu, Özlem KUTLU, Özlem Kutlu¹
ORCID: 0000-0001-5050-3333
Observed ORCID: 0000-0001-5050-3333
OpenAlex ID: A5037637992
A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy
2025 · Sabin Goktas Aydin, Ahmet Aydin, et al. · Supportive Care in Cancer · 2
Pretreatment Claudin-18.2 Expression Predicts Poorer Survival Outcomes in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy
2026 · Gürkan Gül, Özlem Kutlu, et al. · Diagnostics · 1
PDF
Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making
2025 · Özlem Kutlu, Damla Günenç, et al. · Diagnostics · 1
PDF
Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial
2026 · Filippo Ghelardi, Margherita Ambrosini, et al. · Nature Medicine
PDF
Immunoscore and Post-Neoadjuvant Pathological Features in Microsatellite-Stable Locally Advanced Gastric Cancer: A Retrospective Cohort Study
2026 · Özlem Kutlu, Gürkan Gül, et al. · Cancers
Association of Baseline Serum DKK-1 Levels with Subsequent Bone Metastasis in Stage III Breast Cancer
2026 · Gürkan Gül, Damla Günenç, et al. · Medicina
Association of Abdominal Aortic Calcification with Pathological Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Retrospective Exploratory Study
2026 · Özlem Kutlu, Cemre Özenbaş, et al. · Asian Pacific Journal of Cancer Prevention
PDF
Tumour–Stroma Ratio and Platinum Resistance in Epithelial Ovarian Cancer: An Exploratory Analysis
2026 · Gürkan Gül¹, Özlem Kutlu¹, et al. · Cancers
The Prognostic Role of the Lung Immune Prognostic Index in Neuroendocrine Prostate Cancer: A Multicenter Retrospective Study
2026 · Merve Turan, Mehmet Nuri Baser, et al. · Diagnostics
Pretreatment Hemoglobin, Albumin, Lymphocyte, and Platelet Score Predicts Pathological Response and Postoperative Pathological Findings in Locally Advanced Gastric Cancer
2026 · Özlem KUTLU, Gürkan GÜL, et al. · Journal of Oncological Sciences
PDF
Clinical outcomes of adjuvant treatment strategies in locally advanced gastroesophageal and gastric adenocarcinoma with poor pathological response to neoadjuvant FLOT: A Turkish Oncology Group (TOG) study.
2026 · Atilla Çiftçi, Özlem Kutlu, et al. · Journal of Clinical Oncology
PDF
Conditional survival following first-line treatment of MSS metastatic colorectal cancer: A pooled analysis of 12 randomized controlled trials.
2026 · Johannes Werner, Marco Maria Germani, et al. · Journal of Clinical Oncology
National Trends and Factors Affecting the Utilization of Neoadjuvant Chemotherapy
2022 · E. Vega, S. Mellado, et al. · HPB
PDF
Works count: 13
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type